VSV-IFNbeta-NIS

N/A

Report date: 2023/05/05 16:59:30

Base Information

Drug NameVSV-IFNbeta-NIS
Drug Alias NameVSV-IFNβ-NISVoyager V1 - VyriadVSV-IFNβ-NIS - Vyriad
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterferon beta modulators
TargetsInterferon beta
Therapy Area/IndicationsSolid tumoursAngioimmunoblastic T-cell LymphomaMyelodysplastic Syndromes +[20] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVyriad
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteVyriad Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursAngioimmunoblastic T-cell LymphomaMyelodysplastic Syndromes +[20] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A